BrainHeart Therapeutics

Established in 2021, the medical device company is based in the technology park of Andalucia, Malaga, and focuses on two main business and R&D programs**:**

·        Transforming Critical Care with Portable AI ECMO-Cooler Technology: ·       

This project introduces three entirely new medical devices and one significant enhancement to an existing technology:

1. The AI ECMO COOL Platform is a disruptive innovation that expands ECMO's functionality from a passive life-

support system to an active treatment solution integrating therapeutic hypothermia and AI-driven monitoring.

2. The IQ Blood Sensor is a completely new non-invasive technology, replacing manual blood sampling with real-time,

automated analysis.

3. The Point-of-Care Coagulation Monitoring System is an innovative application of microfluidic robotics, enhancing

real-time blood coagulation assessment in ECMO therapy.

Advancing Invasive Brain and Breast Cancer Treatment with Innovation: Our second R&D program focuses on developing a novel invasive technology for treating brain and breast cancers. This disruptive technology has the potential to revolutionize cancer care by offering more effective and less invasive treatment options. While the initial focus is on brain tumors, we have a long-term vision to expand this technology's application to treat breast and lung cancers as well.